{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:07:48Z","timestamp":1789103268800,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82470652"],"award-info":[{"award-number":["82470652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82470652"],"award-info":[{"award-number":["82470652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sichuan Natural Science Foundation project","award":["24NSFSC0237"],"award-info":[{"award-number":["24NSFSC0237"]}]},{"name":"Sichuan Natural Science Foundation project","award":["24NSFSC0237"],"award-info":[{"award-number":["24NSFSC0237"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-02029-8","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T11:05:48Z","timestamp":1770375948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SIRT1-mediated FABP4 destabilization attenuates fibrosis and ferroptosis in non-alcoholic fatty liver disease"],"prefix":"10.1007","volume":"26","author":[{"given":"Haizhou","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"10290","key":"2029_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"issue":"7","key":"2029_CR2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851\u201364.","journal-title":"Gastroenterology"},{"issue":"3","key":"2029_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol. 2019;70(3):531\u201344.","journal-title":"J Hepatol"},{"key":"2029_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101143","volume":"50","author":"KK Bence","year":"2021","unstructured":"Bence KK, Birnbaum MJ. Metabolic drivers of non-alcoholic fatty liver disease. Mol Metab. 2021;50:101143.","journal-title":"Mol Metab"},{"issue":"14","key":"2029_CR5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1055\/s-0041-102787","volume":"140","author":"M Rau","year":"2015","unstructured":"Rau M, Weiss J, Geier A. [Non-alcoholic fatty liver disease (NAFLD)]. Dtsch Med Wochenschr. 2015;140(14):1051\u20135.","journal-title":"Dtsch Med Wochenschr"},{"issue":"5","key":"2029_CR6","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/s10620-016-4079-4","volume":"61","author":"DH Kaswala","year":"2016","unstructured":"Kaswala DH, Lai M, Afdhal NH. Fibrosis assessment in nonalcoholic fatty liver disease (NAFLD) in 2016. Dig Dis Sci. 2016;61(5):1356\u201364.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"2029_CR7","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"Schwabe RF, Tabas I, Pajvani UB. Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology. 2020;158(7):1913\u201328.","journal-title":"Gastroenterology"},{"key":"2029_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113869","volume":"176","author":"S Kumar","year":"2021","unstructured":"Kumar S, Duan Q, Wu R, Harris EN, Su Q. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev. 2021;176:113869.","journal-title":"Adv Drug Deliv Rev"},{"key":"2029_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","volume":"144","author":"G Svegliati-Baroni","year":"2019","unstructured":"Svegliati-Baroni G, Pierantonelli I, Torquato P, Marinelli R, Ferreri C, Chatgilialoglu C, et al. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease. Free Radic Biol Med. 2019;144:293\u2013309.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2029_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3350\/cmh.2022.0237","volume":"29","author":"KC Lee","year":"2023","unstructured":"Lee KC, Wu PS, Lin HC. Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis. Clin Mol Hepatol. 2023;29(1):77\u201398.","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"2029_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/hep4.1341","volume":"3","author":"Y Xu","year":"2019","unstructured":"Xu Y, Zhu Y, Jadhav K, Li Y, Sun H, Yin L, et al. Lipocalin-2 protects against diet-induced nonalcoholic fatty liver disease by targeting hepatocytes. Hepatol Commun. 2019;3(6):763\u201375.","journal-title":"Hepatol Commun"},{"issue":"2","key":"2029_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88.","journal-title":"Cell Death Dis"},{"issue":"4","key":"2029_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"2029_CR14","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3390\/biomedicines9111660","volume":"9","author":"H Zhang","year":"2021","unstructured":"Zhang H, Zhang E, Hu H. Role of ferroptosis in non-alcoholic fatty liver disease and its implications for therapeutic strategies. Biomedicines. 2021;9(11):1660.","journal-title":"Biomedicines"},{"key":"2029_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1090338","volume":"10","author":"Z Cheng","year":"2023","unstructured":"Cheng Z, Chu H, Zhu Q, Yang L. Ferroptosis in non-alcoholic liver disease: molecular mechanisms and therapeutic implications. Front Nutr. 2023;10:1090338.","journal-title":"Front Nutr"},{"key":"2029_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113374","volume":"153","author":"S Wang","year":"2022","unstructured":"Wang S, Liu Z, Geng J, Li L, Feng X. An overview of ferroptosis in non-alcoholic fatty liver disease. Biomed Pharmacother. 2022;153:113374.","journal-title":"Biomed Pharmacother"},{"key":"2029_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174319","volume":"908","author":"M Jia","year":"2021","unstructured":"Jia M, Zhang H, Qin Q, Hou Y, Zhang X, Chen D, et al. Ferroptosis as a new therapeutic opportunity for nonviral liver disease. Eur J Pharmacol. 2021;908:174319.","journal-title":"Eur J Pharmacol"},{"issue":"29","key":"2029_CR18","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1080\/10408398.2022.2070722","volume":"63","author":"S Pande","year":"2023","unstructured":"Pande S, Raisuddin S. Molecular and cellular regulatory roles of Sirtuin protein. Crit Rev Food Sci Nutr. 2023;63(29):9895\u2013913.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"2029_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7150\/ijbs.78654","volume":"19","author":"C Lu","year":"2023","unstructured":"Lu C, Zhao H, Liu Y, Yang Z, Yao H, Liu T, et al. Novel role of the SIRT1 in endocrine and metabolic diseases. Int J Biol Sci. 2023;19(2):484\u2013501.","journal-title":"Int J Biol Sci"},{"key":"2029_CR20","doi-asserted-by":"publisher","first-page":"1525294","DOI":"10.3389\/fcell.2025.1525294","volume":"13","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Kong F, Li N, Tao L, Zhai J, Ma J, et al. Potential role of SIRT1 in cell ferroptosis. Front Cell Dev Biol. 2025;13:1525294.","journal-title":"Front Cell Dev Biol"},{"key":"2029_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9069825","volume":"2022","author":"B Yuan","year":"2022","unstructured":"Yuan B, Zhao XD, Shen JD, Chen SJ, Huang HY, Zhou XM, et al. Activation of SIRT1 alleviates ferroptosis in the early brain injury after subarachnoid hemorrhage. Oxid Med Cell Longev. 2022;2022:9069825.","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"2029_CR22","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1194\/jlr.S091793","volume":"60","author":"KJ Prentice","year":"2019","unstructured":"Prentice KJ, Saksi J, Hotamisligil GS. Adipokine FABP4 integrates energy stores and counterregulatory metabolic responses. J Lipid Res. 2019;60(4):734\u201340.","journal-title":"J Lipid Res"},{"issue":"10","key":"2029_CR23","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrendo.2015.122","volume":"11","author":"GS Hotamisligil","year":"2015","unstructured":"Hotamisligil GS, Bernlohr DA. Metabolic functions of FABPs\u2013mechanisms and therapeutic implications. Nat Rev Endocrinol. 2015;11(10):592\u2013605.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2029_CR24","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/acer.14828","volume":"46","author":"N Attal","year":"2022","unstructured":"Attal N, Marrero E, Thompson KJ, McKillop IH. Cytochrome P450 2E1-dependent hepatic ethanol metabolism induces fatty acid-binding protein 4 and steatosis. Alcohol Clin Exp Res. 2022;46(6):928\u201340.","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"2029_CR25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.4149\/neo_2022_220107N28","volume":"69","author":"Z Li","year":"2022","unstructured":"Li Z, Yu DP, Wang N, Tao T, Luo W, Chen H. SIRT5 promotes non-small cell lung cancer progression by reducing FABP4 acetylation level. Neoplasma. 2022;69(4):909\u201317.","journal-title":"Neoplasma"},{"issue":"9","key":"2029_CR26","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2337\/db18-1367","volume":"68","author":"A Josephrajan","year":"2019","unstructured":"Josephrajan A, Hertzel AV, Bohm EK, McBurney MW, Imai SI, Mashek DG, et al. Unconventional secretion of adipocyte fatty acid binding protein 4 is mediated by autophagic proteins in a Sirtuin-1-dependent manner. Diabetes. 2019;68(9):1767\u201377.","journal-title":"Diabetes"},{"issue":"2","key":"2029_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","volume":"69","author":"T Tsuchida","year":"2018","unstructured":"Tsuchida T, Lee YA, Fujiwara N, Ybanez M, Allen B, Martins S, et al. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J Hepatol. 2018;69(2):385\u201395.","journal-title":"J Hepatol"},{"issue":"2","key":"2029_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jpha.2022.11.010","volume":"13","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liu X, Liu L, Wang Y, Zheng J, Li L, et al. SUMO1 regulates post-infarct cardiac repair based on cellular heterogeneity. J Pharm Anal. 2023;13(2):170\u201386.","journal-title":"J Pharm Anal"},{"key":"2029_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109895","volume":"125","author":"B Liu","year":"2020","unstructured":"Liu B, Deng X, Jiang Q, Li G, Zhang J, Zhang N, et al. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS\/P38\/Nrf2 axis and PI3K\/AKT\/mTOR pathway in macrophages. Biomed Pharmacother. 2020;125:109895.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2029_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13020-024-00953-7","volume":"19","author":"X Xue","year":"2024","unstructured":"Xue X, Wang L, Wu R, Li Y, Liu R, Ma Z, et al. Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice. Chin Med. 2024;19(1):79.","journal-title":"Chin Med"},{"issue":"11","key":"2029_CR31","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4690","volume":"13","author":"Y Miao","year":"2023","unstructured":"Miao Y, Du Q, Zhang HG, Yuan Y, Zuo Y, Zheng H. Cycloheximide (CHX) chase assay to examine protein half-life. BIO-PROTOCOL. 2023;13(11):e4690.","journal-title":"BIO-PROTOCOL"},{"issue":"1","key":"2029_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s10020-019-0085-2","volume":"25","author":"JK Long","year":"2019","unstructured":"Long JK, Dai W, Zheng YW, Zhao SP. MiR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Mol Med. 2019;25(1):26.","journal-title":"Mol Med"},{"issue":"6","key":"2029_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","volume":"10","author":"S Tsurusaki","year":"2019","unstructured":"Tsurusaki S, Tsuchiya Y, Koumura T, Nakasone M, Sakamoto T, Matsuoka M, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis. 2019;10(6):449.","journal-title":"Cell Death Dis"},{"issue":"2","key":"2029_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3803\/EnM.2022.1604","volume":"38","author":"J Chen","year":"2023","unstructured":"Chen J, Wu K, Lei Y, Huang M, Cheng L, Guan H, et al. Inhibition of fatty acid beta-Oxidation by fatty acid binding protein 4 induces ferroptosis in HK2 cells under high glucose conditions. Endocrinol Metab (Seoul). 2023;38(2):226\u201344.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"11","key":"2029_CR35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.tibs.2008.08.001","volume":"33","author":"HS Kwon","year":"2008","unstructured":"Kwon HS, Ott M. The ups and downs of SIRT1. Trends Biochem Sci. 2008;33(11):517\u201325.","journal-title":"Trends Biochem Sci"},{"key":"2029_CR36","doi-asserted-by":"publisher","first-page":"1186231","DOI":"10.3389\/fimmu.2023.1186231","volume":"14","author":"Z Tao","year":"2023","unstructured":"Tao Z, Jin Z, Wu J, Cai G, Yu X. Sirtuin family in autoimmune diseases. Front Immunol. 2023;14:1186231.","journal-title":"Front Immunol"},{"key":"2029_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.107037","volume":"199","author":"S Shen","year":"2024","unstructured":"Shen S, Shen M, Kuang L, Yang K, Wu S, Liu X, et al. SIRT1\/SREBPs-mediated regulation of lipid metabolism. Pharmacol Res. 2024;199:107037.","journal-title":"Pharmacol Res"},{"key":"2029_CR38","doi-asserted-by":"publisher","first-page":"1422541","DOI":"10.3389\/fimmu.2024.1422541","volume":"15","author":"Y Lu","year":"2024","unstructured":"Lu Y, Tang X, Wang W, Yang J, Wang S. The role of deacetylase SIRT1 in allergic diseases. Front Immunol. 2024;15:1422541.","journal-title":"Front Immunol"},{"key":"2029_CR39","doi-asserted-by":"publisher","first-page":"16013","DOI":"10.1038\/srep16013","volume":"5","author":"W Zeng","year":"2015","unstructured":"Zeng W, Shan W, Gao L, Gao D, Hu Y, Wang G, et al. Inhibition of HMGB1 release via Salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease. Sci Rep. 2015;5:16013.","journal-title":"Sci Rep"},{"issue":"3","key":"2029_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.15403\/jgld.2014.1121.233.yck","volume":"23","author":"Y Colak","year":"2014","unstructured":"Colak Y, Yesil A, Mutlu HH, Caklili OT, Ulasoglu C, Senates E, et al. A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators. J Gastrointestin Liver Dis. 2014;23(3):311\u20139.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"1","key":"2029_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01257-8","volume":"7","author":"QJ Wu","year":"2022","unstructured":"Wu QJ, Zhang TN, Chen HH, Yu XF, Lv JL, Liu YY, et al. The sirtuin family in health and disease. Signal Transduct Target Ther. 2022;7(1):402.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2029_CR42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/med.22076","volume":"45","author":"F Fiorentino","year":"2025","unstructured":"Fiorentino F, Fabbrizi E, Mai A, Rotili D. Activation and inhibition of sirtuins: from bench to bedside. Med Res Rev. 2025;45(2):484\u2013560.","journal-title":"Med Res Rev"},{"issue":"7","key":"2029_CR43","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1681\/ASN.2017111218","volume":"29","author":"M Morigi","year":"2018","unstructured":"Morigi M, Perico L, Benigni A. Sirtuins in renal health and disease. J Am Soc Nephrol. 2018;29(7):1799\u2013809.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2029_CR44","first-page":"410","volume":"44","author":"T Wu","year":"2014","unstructured":"Wu T, Liu YH, Fu YC, Liu XM, Zhou XH. Direct evidence of sirtuin downregulation in the liver of non-alcoholic fatty liver disease patients. Ann Clin Lab Sci. 2014;44(4):410\u20138.","journal-title":"Ann Clin Lab Sci"},{"issue":"46","key":"2029_CR45","doi-asserted-by":"publisher","first-page":"10084","DOI":"10.3748\/wjg.v22.i46.10084","volume":"22","author":"F Nassir","year":"2016","unstructured":"Nassir F, Ibdah JA. Sirtuins and nonalcoholic fatty liver disease. World J Gastroenterol. 2016;22(46):10084\u201392.","journal-title":"World J Gastroenterol"},{"key":"2029_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107155","volume":"203","author":"C Tian","year":"2024","unstructured":"Tian C, Huang R, Xiang M. SIRT1: harnessing multiple pathways to hinder NAFLD. Pharmacol Res. 2024;203:107155.","journal-title":"Pharmacol Res"},{"issue":"8","key":"2029_CR47","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/biom12081079","volume":"12","author":"C Zeng","year":"2022","unstructured":"Zeng C, Chen M. Progress in nonalcoholic fatty liver disease: SIRT family regulates mitochondrial biogenesis. Biomolecules. 2022;12(8):1079.","journal-title":"Biomolecules"},{"issue":"3","key":"2029_CR48","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/ijms19030911","volume":"19","author":"JA Del Campo","year":"2018","unstructured":"Del Campo JA, Gallego-Duran R, Gallego P, Grande L. Genetic and epigenetic regulation in nonalcoholic fatty liver disease (NAFLD). Int J Mol Sci. 2018;19(3):911.","journal-title":"Int J Mol Sci"},{"key":"2029_CR49","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.2147\/DMSO.S437865","volume":"16","author":"D Meng","year":"2023","unstructured":"Meng D, Zhang F, Yu W, Zhang X, Yin G, Liang P, et al. Biological role and related natural products of SIRT1 in nonalcoholic fatty liver. Diabetes Metab Syndr Obes. 2023;16:4043\u201364.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"2029_CR50","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bbrc.2016.06.154","volume":"478","author":"B Qu","year":"2016","unstructured":"Qu B, Ma Y, Yan M, Gong K, Liang F, Deng S, et al. Sirtuin1 promotes osteogenic differentiation through downregulation of peroxisome proliferator-activated receptor gamma in MC3T3-E1 cells. Biochem Biophys Res Commun. 2016;478(1):439\u201345.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2029_CR51","doi-asserted-by":"publisher","first-page":"10540","DOI":"10.1080\/21655979.2022.2062533","volume":"13","author":"X Fan","year":"2022","unstructured":"Fan X, Xu M, Ren Q, Fan Y, Liu B, Chen J, et al. Downregulation of fatty acid binding protein 4 alleviates lipid peroxidation and oxidative stress in diabetic retinopathy by regulating peroxisome proliferator-activated receptor gamma-mediated ferroptosis. Bioengineered. 2022;13(4):10540\u201351.","journal-title":"Bioengineered"},{"issue":"1","key":"2029_CR52","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s12013-024-01530-3","volume":"83","author":"S Qi","year":"2025","unstructured":"Qi S. Inhibition of FABP4 ameliorates IL-13-induced inflammatory response and barrier dysfunction in nasal mucosal epithelial cells through the regulation of ferroptosis. Cell Biochem Biophys. 2025;83(1):977\u201387.","journal-title":"Cell Biochem Biophys"},{"key":"2029_CR53","doi-asserted-by":"publisher","first-page":"156738","DOI":"10.1016\/j.phymed.2025.156738","volume":"141","author":"WM Zhao","year":"2025","unstructured":"Zhao WM, Chu F, Zhu JX, Li XL, Zhu Y, Wang ZJ, et al. Diosmin attenuates UUO-induced renal ferroptosis and fibrosis by inhibiting the HIF-1alpha\/FABP4 signaling axis. Phytomedicine. 2025;141:156738.","journal-title":"Phytomedicine"},{"issue":"1","key":"2029_CR54","doi-asserted-by":"publisher","first-page":"21135","DOI":"10.1038\/s41598-024-71311-8","volume":"14","author":"H Xing","year":"2024","unstructured":"Xing H, Wu Z, Jiang K, Yuan G, Guo Z, Yu S, et al. FABP4 deficiency ameliorates alcoholic steatohepatitis in mice via inhibition of p53 signaling pathway. Sci Rep. 2024;14(1):21135.","journal-title":"Sci Rep"},{"issue":"13","key":"2029_CR55","doi-asserted-by":"publisher","first-page":"11032","DOI":"10.3390\/ijms241311032","volume":"24","author":"HM Kim","year":"2023","unstructured":"Kim HM, Zheng X, Lee E. Experimental insights into the interplay between histone modifiers and p53 in regulating gene expression. Int J Mol Sci. 2023;24(13):11032.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2029_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101684","volume":"5","author":"B Lian","year":"2024","unstructured":"Lian B, Zhang J, Yin X, Wang J, Li L, Ju Q, et al. SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via deacetylation and inhibition of PKM2. Cell Rep Med. 2024;5(8):101684.","journal-title":"Cell Rep Med"},{"issue":"8","key":"2029_CR57","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.4049\/jimmunol.2200601","volume":"210","author":"Y Kurihara","year":"2023","unstructured":"Kurihara Y, Walenna NF, Ishii K, Soejima T, Chou B, Yoshimura M, et al. Chlamydia pneumoniae lung infection in mice induces fatty acid-binding protein 4-dependent white adipose tissue pathology. J Immunol. 2023;210(8):1086\u201397.","journal-title":"J Immunol"},{"issue":"4","key":"2029_CR58","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jhep.2015.05.030","volume":"63","author":"B Hu","year":"2015","unstructured":"Hu B, Guo Y, Garbacz WG, Jiang M, Xu M, Huang H, et al. Fatty acid binding protein-4 (FABP4) is a hypoxia inducible gene that sensitizes mice to liver ischemia\/reperfusion injury. J Hepatol. 2015;63(4):855\u201362.","journal-title":"J Hepatol"},{"issue":"3","key":"2029_CR59","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10456-012-9274-0","volume":"15","author":"H Elmasri","year":"2012","unstructured":"Elmasri H, Ghelfi E, Yu CW, Traphagen S, Cernadas M, Cao H, et al. Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor\/c-kit pathway. Angiogenesis. 2012;15(3):457\u201368.","journal-title":"Angiogenesis"},{"issue":"4","key":"2029_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/arch.21649","volume":"103","author":"Y Ma","year":"2020","unstructured":"Ma Y, Wu C, Liu J, Liu Y, Lv J, Sun Z, et al. The stability and antiapoptotic activity of Bm30K-3 can be improved by lysine acetylation in the silkworm, Bombyx mori. Arch Insect Biochem Physiol. 2020;103(4):e21649.","journal-title":"Arch Insect Biochem Physiol"},{"issue":"1","key":"2029_CR61","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1038\/s41467-023-40224-x","volume":"14","author":"UH Guzman","year":"2023","unstructured":"Guzman UH, Aksnes H, Ree R, Krogh N, Jakobsson ME, Jensen LJ, et al. Loss of N-terminal acetyltransferase A activity induces thermally unstable ribosomal proteins and increases their turnover in Saccharomyces cerevisiae. Nat Commun. 2023;14(1):4517.","journal-title":"Nat Commun"},{"issue":"1","key":"2029_CR62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/febs.15824","volume":"289","author":"A Gubas","year":"2022","unstructured":"Gubas A, Dikic I. A guide to the regulation of selective autophagy receptors. FEBS J. 2022;289(1):75\u201389.","journal-title":"FEBS J"},{"issue":"8","key":"2029_CR63","doi-asserted-by":"publisher","first-page":"e0742","DOI":"10.1097\/HC9.0000000000000742","volume":"9","author":"Y Duan","year":"2025","unstructured":"Duan Y, Peng S, Yue J, Ding F, Chen X, Pan W, et al. SLC1A5-dependent glutamine uptake in hepatocytes promotes liver regeneration. Hepatol Commun. 2025;9(8):e0742.","journal-title":"Hepatol Commun"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-02029-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-02029-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-02029-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:03:40Z","timestamp":1770692620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-02029-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2029"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-02029-8","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures complied with the NIH Guide for the Care and Use of Laboratory Animals and were reviewed and approved by the institutional animal ethics committee of West China Hospital, Sichuan University (ethics approval No. 2021275\u00a0A).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"129"}}